Bombard DS, Mousa SA. Mayer-Rokitansky-Kuster-Hauser syndrome: complications, diagnosis and possible treatment options: a review. Gynecol Endocrinol. 2014;30:618–23.
Choussein S, Nasioudis D, Schizas D, Economopoulos KP. Mullerian dysgenesis: a critical review of the literature. Arch Gynecol Obstet. 2017;295:1369–81.
Callens N, de Cuypere G, Wolffenbuttel KP, Beerendonk CC, van der Zwan YG, van den Berg M, et al. Long-term psychosexual and anatomical outcome after vaginal dilation or vaginoplasty: a comparative study. J Sex Med. 2012;9:1842–51.
Schober JM. Cancer of the neovagina. J Pediatr Urol. 2007;3:167–70.
Imparato E, Alfei A, Aspesi G, Meus AL, Spinillo A. Long-term results of sigmoid vaginoplasty in a consecutive series of 62 patients. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:1465–9.
Sueters J, Groenman FA, Bouman M-B, Roovers JPW, de Vries R, Smit TH, et al. Tissue engineering neovagina for vaginoplasty in Mayer–Rokitansky–Küster–Hauser syndrome and gender dysphoria patients: a systematic review. Tissue Eng Part B Rev. 2022;29:28–46.
de Filippo RE, Bishop CE, Filho LF, Yoo JJ, Atala A. Tissue engineering a complete vaginal replacement from a small biopsy of autologous tissue. Transplantation. 2008;86:208–14.
Atala A. Regenerative medicine and tissue engineering in urology. Urol Clin North Am. 2009;36:199–209.
de Filippo RE, Yoo JJ, Atala A. Engineering of vaginal tissue in vivo. Tissue Eng. 2003;9:301–6.
Namhongsa M, Daranarong D, Sriyai M, Molloy R, Ross S, Ross GM, et al. Surface-modified polypyrrole-coated PLCL and PLGA nerve guide conduits fabricated by 3D printing and electrospinning. Biomacromol. 2022;23:4532–46.
Jeong SI, Kim SH, Kim YH, Jung Y, Kwon JH, Kim BS, et al. Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering. J Biomater Sci Polym Ed. 2004;15:645–60.
Fu W, Liu Z, Feng B, Hu R, He X, Wang H, et al. Electrospun gelatin/PCL and collagen/PLCL scaffolds for vascular tissue engineering. Int J Nanomedicine. 2014;9:2335–44.
Sartoneva R, Haimi S, Miettinen S, Mannerström B, Haaparanta A-M, Sándor GK, et al. Comparison of a poly-L-lactide-co-ε-caprolactone and human amniotic membrane for urothelium tissue engineering applications. J R Soc Interface. 2011;8:671–7.
Sartoneva R, Haaparanta AM, Lahdes-Vasama T, Mannerström B, Kellomäki M, Salomäki M, et al. Characterizing and optimizing poly-L-lactide-co-epsilon-caprolactone membranes for urothelial tissue engineering. J R Soc Interface. 2012;9:3444–54.
Sartoneva R, Nordback PHH, Haimi S, Grijpma DWW, Lehto K, Rooney N, et al. Comparison of poly(l-lactide-co-varepsilon-caprolactone) and Poly(trimethylene carbonate) membranes for urethral regeneration: an in vitro and in vivo study. Tissue Eng Part A. 2017;24:117–27.
Sartoneva R, Kuismanen K, Juntunen M, Karjalainen S, Hannula M, Kyllönen L, et al. Porous poly-L-lactide-co-1-caprolactone scaffold: a novel biomaterial for vaginal tissue engineering. R Soc Open Sci. 2018;5: 180811.
Asikainen S, Paakinaho K, Kyhkynen AK, Hannula M, Malin M, Ahola N, et al. Hydrolysis and drug release from poly(ethylene glycol)-modified lactone polymers with open porosity. Eur Polym J. 2019;113:165–75.
Vuornos K, Bjorninen M, Talvitie E, Paakinaho K, Kellomaki M, Huhtala H, et al. Human adipose stem cells differentiated on braided polylactide scaffolds is a potential approach for tendon tissue engineering. Tissue Eng Part A. 2016;22:513–23.
Kim SH, Jung Y, Kim SH. A biocompatible tissue scaffold produced by supercritical fluid processing for cartilage tissue engineering. Tissue Engineering Part C Methods. 2013;19:181–8.
He Y, Liu W, Guan L, Chen J, Duan L, Jia Z, et al. A 3D-printed PLCL scaffold coated with collagen type I and its biocompatibility. Biomed Res Int. 2018;2018:5147156.
Jin D, Hu J, Xia D, Liu A, Kuang H, Du J, et al. Evaluation of a simple off-the-shelf bi-layered vascular scaffold based on poly(L-lactide-co-ε-caprolactone)/silk fibroin in vitro and in vivo. Int J Nanomedicine. 2019;14:4261–76.
Piersma B, Wouters OY, de Rond S, Boersema M, Gjaltema RAF, Bank RA. Ascorbic acid promotes a TGFβ1-induced myofibroblast phenotype switch. Physiol Rep. 2017;5:e13324.
Choi KM, Seo YK, Yoon HH, Song KY, Kwon SY, Lee HS, et al. Effect of ascorbic acid on bone marrow-derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng. 2008;105:586–94.
Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy. 2003;5:362–9.
Austria R, Semenzato A, Bettero A. Stability of vitamin C derivatives in solution and topical formulations. J Pharm Biomed Anal. 1997;15:795–801.
Mangir N, Bullock AJ, Roman S, Osman N, Chapple C, MacNeil S. Production of ascorbic acid releasing biomaterials for pelvic floor repair. Acta Biomater. 2016;29:188–97.
Takamizawa S, Maehata Y, Imai K, Senoo H, Sato S, Hata R. Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells. Cell Biol Int. 2004;28:255–65.
Yu J, Tu YK, Tang YB, Cheng NC. Stemness and transdifferentiation of adipose-derived stem cells using l-ascorbic acid 2-phosphate-induced cell sheet formation. Biomaterials. 2014;35:3516–26.
Osman NI, Roman S, Bullock AJ, Chapple CR, Macneil S. The effect of ascorbic acid and fluid flow stimulation on the mechanical properties of a tissue engineered pelvic floor repair material. Proc Inst Mech Eng H. 2014;228:867–75.
Zhao X, Lui YS, Toh PWJ, Loo SCJ. Sustained release of hydrophilic L-ascorbic acid 2-phosphate magnesium from electrospun polycaprolactone scaffold-A study across blend, coaxial, and emulsion electrospinning techniques. Materials. 2014;7:7398–408.
Kim H, Kim HW, Suh H. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Biomaterials. 2003;24:4671–9.
Doube M, Klosowski MM, Arganda-Carreras I, Cordelieres FP, Dougherty RP, Jackson JS, et al. BoneJ: free and extensible bone image analysis in ImageJ. Bone. 2010;47:1076–9.
Palmroth A, Pitkänen S, Hannula M, Paakinaho K, Hyttinen J, Miettinen S, et al. Evaluation of scaffold microstructure and comparison of cell seeding methods using micro-computed tomography-based tools. J R Soc Interface. 2020;17:20200102.
Kurki A, Paakinaho K, Hannula M, Hyttinen J, Miettinen S, Sartoneva R. Ascorbic acid 2-phosphate-releasing supercritical carbon dioxide-foamed poly(l-lactide-co-epsilon-caprolactone) scaffolds support urothelial cell growth and enhance human adipose-derived stromal cell proliferation and collagen production. J Tissue Eng Regen Med. 2023;2023:6404468.
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
Guler Z, Roovers JP. Role of fibroblasts and myofibroblasts on the pathogenesis and treatment of pelvic organ prolapse. Biomolecules. 2022;12:94.
Horst M, Madduri S, Gobet R, Sulser T, Milleret V, Hall H, et al. Engineering functional bladder tissues. J Tissue Eng Regen Med. 2013;7:515–22.
Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403–39.
Mangir N, Roman S, Macneil S. Improving the biocompatibility of biomaterial constructs and constructs delivering cells for the pelvic floor. Curr Opin Urol. 2019;29:419–25.
Arrigoni O, De Tullio MC. Ascorbic acid: much more than just an antioxidant. Biochim Biophys Acta. 2002;15:1–9.
Hung M, Wen M, Hung C, Ho ES, Chen G, Yang VC. Tissue-engineered fascia from vaginal fibroblasts for patientsneeding reconstructive pelvic surgery. Int Urogynecol J. 2010;21:1085–93.
Patrikoski M, Mannerström B, Miettinen S. Perspectives for clinical translation of adipose stromal/stem cells. Stem Cells Int. 2019;2019:16–8.
Kuismanen K, Sartoneva R, Haimi S, Mannerström B, Tomás E, Miettinen S, et al. Autologous adipose stem cells in treatment of female stress urinary incontinence: results of a pilot study. Stem Cells Transl Med. 2014;3:936–41.